Biotest AG, DE0005227235

Biotest AG, DE0005227235

02.02.2018 - 10:46:56

Biotest AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Biotest AG Landsteinerstraße 5 63303 Dreieich Germany 2. Reason for notification X Acquisition/disposal of shares with voting rights   Acquisition/disposal of instruments   Change of breakdown of voting rights   Other reason: 3. Details of person subject to the notification obligation Name: City and country of registered office: Mr Yuewen Zheng,Date of birth: 11 Jan 1962 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.Tiancheng (Germany) Pharmaceutical Holdings AG 5. Date on which threshold was crossed or reached: 31 Jan 2018 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 89.88 % 0 % 89.88 % 19785726 Previous notification 0 % 0 % 0 % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 33, 34 WpHG) ISIN absolute in %   direct (Sec. 33 WpHG) indirect (Sec. 34 WpHG) direct (Sec. 33 WpHG) indirect (Sec. 34 WpHG) DE0005227201 17783776 % 89.88 % Total 17783776 89.88 % b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % %     Total % b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % %       Total % 8. Information in relation to the person subject to the notification obligation  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more) Yuewen Zheng % % %   Creat Group Co., Ltd. % % %   Creat Tiancheng Investment Holdings Co., Ltd. % % %   Tiancheng Fortune Management Limited % % %   Tiancheng International Investment Limited % % %   Tiancheng (Germany) Pharmaceutical Holdings AG 89.88 % % 89.88 % 9. In case of proxy voting according to Sec. 34 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: 

02.02.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Biotest AG Landsteinerstraße 5 63303 Dreieich

Germany Internet: http://www.biotest.de   End of News DGAP News Service

650875  02.02.2018 

@ dgap.de

Amazon wird sich schwarzärgern, aber …

… wir schenken Ihnen den Report „Börsenpsychologie - Markttechnik für Trader“ heute trotzdem kostenfrei. Normalerweise kostet der Report im Onlinehandel 39,99 Euro.

Sie können sich den genialen Report heute jedoch absolut kostenfrei sichern. Wir senden Ihnen den Report vollkommen KOSTENFREI zu.

Jetzt HIER klicken und dank richtigen Timing reich an der Börse werden!